de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Poster

Characterization of AGE1.CR.pIX high cell density cultivations for vaccinia virus production

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86389

Lohr,  Verena
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Blechert,  Anne-Kareen
Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86303

Genzel,  Yvonne
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  Udo
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Lohr, V., Blechert, A.-K., Genzel, Y., Jordan, I., & Reichl, U. (2012). Characterization of AGE1.CR.pIX high cell density cultivations for vaccinia virus production. Poster presented at GVC/DECHEMA Vortrags- und Diskussionstagung Biopharmazeutische Produktion, Freiburg, Germany.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0013-88EF-F
Zusammenfassung
Recently, the suitability of the avian suspension cell line AGE1.CR.pIX as a producer cell line for vaccinia virus in a chemically-defined process was demonstrated. Normally, one would expect that higher cell densities should lead to higher virus yields. However, for many viruses the so called cell density effect results in reduced yields at high cell densities and thus limits the production capacity. To understand whether a cell density effect occurs in this vaccinia production process, we monitored cell physiology of AGE1.CR.pIX cells before and after virus infection. A recombinant modified vaccinia virus with an enhanced green fluorescence protein (egfp) insert was used. Cultures were infected after 3 or 5 days of batch growth at 4x106 cells/mL and 8x106 cells/mL, respectively, by adding an equal volume of production medium. We analyzed five parameters: i) cell viability, ii) cell cycle distribution by measuring DNA content, iii) apoptosis via annexin V staining, iv) infection status via detection of intracellular egfp and v) virus titer. Experimental data did not indicate a cell density effect. No significant alterations of the cell population neither in terms of cell viability, nor in cell cycle proportions or fraction of apoptotic cells were observed in high cell density cultures. Cell-specific virus yields were also not impaired. In contrast, although cell concentration was doubled, virus yields increased by a factor of three and a maximum concentration of 5x108 viruses/mL was reached. As a cell concentration of 8x106 cells/mL can easily be achieved in a batch process, the use of fed-batch or perfusion cultivations could lead to even higher virus yields.